Belldegrun Arie
Insider CIK 1296549 · ARNI Director · KITE Chairman, President and CEO, Director, 10% owner · URGN Director · LBRX 10% owner · ALLO Director, 10% owner · KRON Director · DNA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma Ltd. | A Award deriv | 2026-06-22 | 2026-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2026-02-02 | 2026-02-04 | 263,033 | — | $0 | 263,033 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2026-02-02 | 2026-02-04 | 929,913 | — | $0 | 929,913 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | C Conversion deriv | 2025-09-12 | 2025-09-16 | 13,302,666 | — | $0 | 0 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | C Conversion deriv | 2025-09-12 | 2025-09-16 | 30,667 | — | $0 | 0 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | C Conversion | 2025-09-12 | 2025-09-16 | 1,262 | — | $0 | 1,262 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | C Conversion | 2025-09-12 | 2025-09-16 | 547,648 | — | $0 | 547,648 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | P Buy | 2025-09-12 | 2025-09-16 | 767 | $15.00 | $11.5K | 2,029 | SEC↗ |
| LBRX LB PHARMACEUTICALS INC | P Buy | 2025-09-12 | 2025-09-16 | 332,566 | $15.00 | $4.99M | 880,214 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2025-08-26 | 2025-08-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 20,600 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 34,000 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 34,000 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 34,000 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | U Tender | 2025-06-20 | 2025-06-20 | 2,765,314 | $0.57 | $1.58M | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | U Tender | 2025-06-20 | 2025-06-20 | 679,575 | $0.57 | $387.4K | 0 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2025-01-24 | 2025-01-28 | 1,307,927 | — | $0 | 1,307,927 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2025-01-24 | 2025-01-28 | 369,957 | — | $0 | 2,236,816 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2024-08-06 | 2024-08-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2024-06-25 | 2024-06-26 | 34,000 | — | $0 | 34,000 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | A Award deriv | 2024-06-13 | 2024-06-14 | 432,900 | — | $0 | 432,900 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | A Award deriv | 2024-06-13 | 2024-06-14 | 571,428 | — | $0 | 571,428 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | M Exercise deriv | 2024-06-12 | 2024-06-14 | 105,263 | — | $0 | 0 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | M Exercise | 2024-06-12 | 2024-06-14 | 105,263 | — | $0 | 194,925 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2024-05-16 | 2024-05-20 | 344,828 | $2.90 | $1.00M | 539,867 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | P Buy | 2024-05-16 | 2024-05-20 | 1,724,137 | $2.90 | $5.00M | 1,724,137 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2024-01-25 | 2024-01-31 | 749,398 | — | $0 | 749,398 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2024-01-25 | 2024-01-31 | 211,973 | — | $0 | 1,866,859 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2023-09-07 | 2023-09-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2023-06-22 | 2023-06-26 | 34,000 | — | $0 | 34,000 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | A Award deriv | 2023-06-16 | 2023-06-21 | 105,263 | — | $0 | 105,263 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | A Award deriv | 2023-06-16 | 2023-06-21 | 139,860 | — | $0 | 139,860 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2023-03-22 | 2023-03-24 | 994,800 | — | $0 | 994,800 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2023-03-22 | 2023-03-24 | 1,282,976 | — | $0 | 1,654,886 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2022-09-14 | 2022-09-16 | 160,000 | — | $0 | 0 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2022-09-14 | 2022-09-16 | 160,000 | $5.00 | $800.0K | 408,693 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2022-08-31 | 2022-09-02 | 3,241 | — | $0 | 0 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2022-08-31 | 2022-09-02 | 3,241 | $5.00 | $16.2K | 248,693 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2022-06-22 | 2022-06-29 | 34,000 | — | $0 | 34,000 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | A Award deriv | 2022-06-10 | 2022-06-13 | 108,516 | — | $0 | 108,516 | SEC↗ |
| DNA Ginkgo Bioworks Holdings, | A Award | 2022-06-10 | 2022-06-13 | 70,921 | — | $0 | 89,662 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2022-06-08 | 2022-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2022-03-23 | 2022-03-25 | 1,458,333 | — | $0 | 1,458,333 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2022-03-14 | 2022-04-01 | 4,710,120 | — | $0 | 0 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2022-03-14 | 2022-04-01 | 4,710,120 | — | $0 | 4,710,120 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2022-03-14 | 2022-03-31 | 4,710,121 | — | $0 | 0 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2022-03-14 | 2022-03-31 | 4,710,121 | — | $0 | 4,710,121 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | P Buy | 2022-01-12 | 2022-01-14 | 155,039 | $12.60 | $1.95M | 195,039 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2021-06-22 | 2021-06-23 | 20,600 | — | $0 | 20,600 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2021-06-07 | 2021-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise deriv | 2021-05-24 | 2021-05-25 | 379,066 | — | $0 | 0 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | M Exercise | 2021-05-24 | 2021-05-25 | 379,066 | $18.22 | $6.91M | 583,034 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2021-03-26 | 2021-06-09 | 3,241 | — | $0 | 0 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2021-03-26 | 2021-06-09 | 3,241 | $5.00 | $16.2K | 245,452 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2021-03-26 | 2021-03-30 | 199,223 | — | $0 | 199,223 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2021-03-26 | 2021-03-30 | 53,635 | — | $0 | 203,968 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2021-03-24 | 2021-04-22 | 3,241 | — | $0 | 0 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2021-03-24 | 2021-04-22 | 3,241 | $5.00 | $16.2K | 245,452 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion deriv | 2020-10-14 | 2020-10-16 | 173,333 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion deriv | 2020-10-14 | 2020-10-16 | 1,304,563 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion deriv | 2020-10-14 | 2020-10-16 | 650,000 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion deriv | 2020-10-14 | 2020-10-16 | 228,315 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion deriv | 2020-10-14 | 2020-10-16 | 0 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion | 2020-10-14 | 2020-10-16 | 685,750 | — | $0 | 685,750 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion | 2020-10-14 | 2020-10-16 | 1,376,313 | — | $0 | 2,062,063 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion | 2020-10-14 | 2020-10-16 | 253,251 | $16.15 | $4.09M | 2,315,314 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion | 2020-10-14 | 2020-10-16 | 240,872 | — | $0 | 679,575 | SEC↗ |
| KRON Kronos Bio, Inc. | C Conversion | 2020-10-14 | 2020-10-16 | 182,866 | — | $0 | 438,703 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2020-06-08 | 2020-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | P Buy | 2020-06-04 | 2020-06-04 | 106,382 | $47.00 | $5.00M | 1,798,163 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | P Buy | 2020-06-04 | 2020-06-04 | 40,000 | $47.00 | $1.88M | 40,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2020-03-18 | 2020-03-20 | 379,066 | — | $0 | 379,066 | SEC↗ |
| URGN UroGen Pharma Ltd. | A Award deriv | 2019-06-03 | 2019-06-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2019-05-13 | 2019-05-15 | 13,413 | — | $0 | 515,076 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2019-05-13 | 2019-05-15 | 598,935 | — | $0 | 4,791,480 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2019-04-26 | 2019-04-30 | 13,413 | — | $0 | 501,663 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | J Other | 2019-04-26 | 2019-04-30 | 598,937 | — | $0 | 5,390,415 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise deriv | 2019-03-27 | 2019-03-28 | 128,000 | $4.02 | $514.6K | 0 | SEC↗ |
| URGN UroGen Pharma Ltd. | M Exercise | 2019-03-27 | 2019-03-28 | 128,000 | $4.02 | $514.6K | 212,211 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award deriv | 2019-03-13 | 2019-03-15 | 195,133 | — | $0 | 195,133 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | A Award | 2019-03-13 | 2019-03-15 | 115,333 | — | $0 | 150,333 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | P Buy | 2018-10-15 | 2019-02-13 | 194,445 | $18.00 | $3.50M | 1,691,781 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | C Conversion deriv | 2018-10-15 | 2018-10-17 | 1,140,829 | — | $0 | 0 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | C Conversion deriv | 2018-10-15 | 2018-10-17 | 285,207 | — | $0 | 0 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | C Conversion deriv | 2018-10-15 | 2018-10-17 | 27,095 | — | $0 | 0 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | C Conversion | 2018-10-15 | 2018-10-17 | 142,248 | — | $0 | 3,710,006 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | C Conversion | 2018-10-15 | 2018-10-17 | 5,989,352 | — | $0 | 5,989,352 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | C Conversion | 2018-10-15 | 2018-10-17 | 1,497,336 | — | $0 | 1,497,336 | SEC↗ |
| ALLO Allogene Therapeutics, Inc | P Buy | 2018-10-15 | 2018-10-17 | 35,000 | $18.00 | $630.0K | 35,000 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 56,643 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 159,700 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 44,057 | $116.13 | $5.12M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 43,500 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer deriv | 2017-10-03 | 2017-10-05 | 95,700 | $128.04 | $12.25M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 159,329 | $180.00 | $28.68M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 500,000 | $180.00 | $90.00M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 430,190 | $180.00 | $77.43M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 500,000 | $180.00 | $90.00M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 1,607,750 | $180.00 | $289.39M | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | D To issuer | 2017-10-03 | 2017-10-05 | 159,160 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2017-09-25 | 2017-10-05 | 50,000 | — | $0 | 159,160 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2017-09-25 | 2017-09-27 | 50,000 | — | $0 | 135,507 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2017-09-25 | 2017-09-27 | 26,347 | $179.66 | $4.73M | 109,160 | SEC↗ |
| KITE Kite Pharma, Inc. | P Buy | 2017-05-09 | 2017-05-09 | 17,000 | $68.57 | $1.17M | 85,507 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2016-12-27 | 2016-12-29 | 159,700 | — | $0 | 159,700 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2016-12-27 | 2016-12-29 | 43,800 | — | $0 | 68,507 | SEC↗ |
| KITE Kite Pharma, Inc. | S Sale | 2016-12-20 | 2016-12-22 | 3,493 | $50.86 | $177.7K | 24,707 | SEC↗ |
| KITE Kite Pharma, Inc. | G Gift | 2016-12-09 | 2016-12-29 | 66,000 | — | $0 | 1,607,750 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2016-08-15 | 2016-08-17 | 357,142 | — | $0 | 357,142 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2016-08-15 | 2016-08-17 | 714,285 | — | $0 | 2,262,838 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2016-04-07 | 2016-04-11 | 177,256 | — | $0 | 177,256 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2016-01-12 | 2016-01-14 | 714,285 | $0.35 | $250.0K | 858,094 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2016-01-12 | 2016-01-14 | 1,448,062 | $0.35 | $506.8K | 1,548,543 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2015-12-17 | 2015-12-21 | 100,700 | — | $0 | 100,700 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award | 2015-12-17 | 2015-12-21 | 28,200 | — | $0 | 28,200 | SEC↗ |
| KITE Kite Pharma, Inc. | A Award deriv | 2014-12-24 | 2014-12-30 | 139,200 | — | $0 | 139,200 | SEC↗ |
| KITE Kite Pharma, Inc. | C Conversion deriv | 2014-06-25 | 2014-08-01 | 428,534 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | C Conversion deriv | 2014-06-25 | 2014-08-01 | 396,791 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | C Conversion deriv | 2014-06-25 | 2014-08-01 | 539,636 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | C Conversion deriv | 2014-06-25 | 2014-08-01 | 158,716 | — | $0 | 0 | SEC↗ |
| KITE Kite Pharma, Inc. | C Conversion | 2014-06-25 | 2014-08-01 | 430,190 | — | $0 | 430,190 | SEC↗ |
| KITE Kite Pharma, Inc. | C Conversion | 2014-06-25 | 2014-08-01 | 159,329 | — | $0 | 159,329 | SEC↗ |
| KITE Kite Pharma, Inc. | C Conversion | 2014-06-25 | 2014-08-01 | 541,722 | — | $0 | 2,275,472 | SEC↗ |
| KITE Kite Pharma, Inc. | C Conversion | 2014-06-25 | 2014-08-01 | 398,324 | — | $0 | 2,138,324 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2014-01-24 | 2014-01-28 | 68,448 | — | $0 | 68,448 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2013-11-04 | 2013-11-06 | 3,559,296 | — | $0 | 3,559,296 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-11-05 | 104,166 | — | $0 | 104,166 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-11-05 | 187,500 | — | $0 | 187,500 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2013-10-29 | 2013-11-05 | 145,833 | — | $0 | 145,833 | SEC↗ |
| ARNI Arno Therapeutics, Inc | D To issuer deriv | 2013-10-29 | 2013-11-05 | 145,833 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion deriv | 2013-10-29 | 2013-11-05 | 145,833 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-11-05 | 104,166 | — | $0 | 104,166 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-11-05 | 187,500 | — | $0 | 187,500 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2013-10-29 | 2013-11-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| ARNI Arno Therapeutics, Inc | D To issuer deriv | 2013-10-29 | 2013-11-05 | 125,000 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion deriv | 2013-10-29 | 2013-11-05 | 125,000 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-11-05 | 104,166 | — | $0 | 104,166 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-11-05 | 104,166 | — | $0 | 104,166 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2013-10-29 | 2013-11-05 | 83,333 | — | $0 | 83,333 | SEC↗ |
| ARNI Arno Therapeutics, Inc | D To issuer deriv | 2013-10-29 | 2013-11-05 | 83,333 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion deriv | 2013-10-29 | 2013-11-05 | 83,333 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-11-05 | 83,333 | — | $0 | 83,333 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy deriv | 2013-10-29 | 2013-11-05 | 83,333 | — | $0 | 83,333 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award deriv | 2013-10-29 | 2013-11-05 | 62,500 | — | $0 | 62,500 | SEC↗ |
| ARNI Arno Therapeutics, Inc | D To issuer deriv | 2013-10-29 | 2013-11-05 | 62,500 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion deriv | 2013-10-29 | 2013-11-05 | 62,500 | — | $0 | 0 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2013-10-29 | 2013-11-05 | 104,166 | — | $0 | 254,887 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2013-10-29 | 2013-11-05 | 104,166 | — | $0 | 143,809 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion | 2013-10-29 | 2013-11-05 | 133,305 | $2.40 | $319.9K | 140,721 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award | 2013-10-29 | 2013-11-05 | 10,000 | $2.40 | $24.0K | 150,721 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion | 2013-10-29 | 2013-11-05 | 155,523 | $2.40 | $373.3K | 180,128 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award | 2013-10-29 | 2013-11-05 | 11,666 | $2.40 | $28.0K | 191,794 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2013-10-29 | 2013-11-05 | 187,500 | — | $0 | 379,294 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award | 2013-10-29 | 2013-11-05 | 6,666 | $2.40 | $16.0K | 100,481 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion | 2013-10-29 | 2013-11-05 | 66,652 | $2.40 | $160.0K | 86,312 | SEC↗ |
| ARNI Arno Therapeutics, Inc | C Conversion | 2013-10-29 | 2013-11-05 | 88,871 | $2.40 | $213.3K | 93,815 | SEC↗ |
| ARNI Arno Therapeutics, Inc | A Award | 2013-10-29 | 2013-11-05 | 5,000 | $2.40 | $12.0K | 91,312 | SEC↗ |
| ARNI Arno Therapeutics, Inc | P Buy | 2013-10-29 | 2013-11-05 | 83,332 | — | $0 | 174,644 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-05-28 | 2013-06-03 | 22,556 | $0.30 | $6.8K | 196,841 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-05-28 | 2013-06-03 | 12,889 | $0.30 | $3.9K | 39,555 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-05-28 | 2013-06-03 | 9,667 | $0.30 | $2.9K | 157,286 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-05-28 | 2013-06-03 | 19,333 | $0.30 | $5.8K | 59,333 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-04-29 | 2013-05-07 | 20,000 | $0.30 | $6.0K | 40,000 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-04-29 | 2013-05-07 | 23,333 | $0.30 | $7.0K | 174,285 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-04-29 | 2013-05-07 | 10,000 | $0.30 | $3.0K | 147,619 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-04-29 | 2013-05-07 | 13,333 | $0.30 | $4.0K | 26,666 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-03-27 | 2013-04-15 | 20,000 | $0.30 | $6.0K | 20,000 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-03-27 | 2013-04-15 | 23,333 | $0.30 | $7.0K | 150,952 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-03-27 | 2013-04-15 | 13,333 | $0.30 | $4.0K | 13,333 | SEC↗ |
| ARNI Arno Therapeutics, Inc | J Other | 2013-03-27 | 2013-04-15 | 10,000 | $0.30 | $3.0K | 137,619 | SEC↗ |